Latest Breaking News On - Pediatric use marketing authorization - Page 4 : comparemela.com

Fennec Pharmaceuticals Announces European Commission Marketing Authorization for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology Patients

RESEARCH TRIANGLE PARK, N.C., June 06, 2023 Fennec Pharmaceuticals Inc. , a commercial stage specialty pharmaceutical company, today announced Pedmarqsi™– known as PEDMARK® in. | June 6, 2023

United statesLindsay roccoLandierw ototoxicityRobert andradeDrug administrationEuropean commission marketing authorizationFennec pharmaceuticalsFennec pharmaceuticals incTrends in pharmacological sciencesOregon healthScience universityElixir health public relationsClinical oncology groupEuropean commissionChildren oncology groupGlobenewswire inc

Fennec Pharmaceuticals (FENC) Announces European Commission Marketing Authorization for Pedmarqsi

Fennec Pharmaceuticals (FENC) Announces European Commission Marketing Authorization for Pedmarqsi
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLandierw ototoxicityOregon healthExchange commissionDrug administrationFennec pharmaceuticalsfennec pharmaceuticals incTrends in pharmacological sciencesRobert andradechief financial officerfennec pharmaceuticals incFennec pharmaceuticals incChildren oncology groupLindsay rocco elixir health public relationsClinical oncology groupScience universityEuropean commissionAbout cisplatin induced ototoxicityPrescribing information